Genetic testing for lung, head and neck, and mesothelioma
Part of Cancer, Lungs & breathing clinical trials.
This study looks at tumor and blood samples to understand the genetic makeup of certain cancers, which may help guide treatment decisions. It's for people with specific types of lung cancer, head and neck cancer, or mesothelioma who are about to start chemotherapy plus immunotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have one of these cancers: advanced non-small cell lung cancer (without a known targeted gene change), extensive-stage small cell lung cancer that hasn't been treated yet, recurrent or spread squamous cell head and neck cancer that hasn't been treated yet, or malignant pleural mesothelioma.
- Your cancer treatment plan must include chemotherapy (platinum-based) plus an immunotherapy drug, and you need to start within the next 28 days.
- You must be able to give a blood sample for this study.
- You cannot have certain active infections (like hepatitis B or C) or be taking more than 10 mg of prednisone per day.
- You cannot have another cancer that is currently being treated with systemic therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood and tumor samples from people newly diagnosed with small cell lung cancer to study how genetic markers can predict treatment success and monitor disease over time.
This study collects tissue (and follows patients over time) to better understand the natural course of several types of chest cancers. It may help researchers learn which tests and treatments work best in different cancer types.
This study looks at genetic markers in two types of lung cancer (small cell and large cell neuroendocrine) to understand why some tumors stop responding to a standard treatment that combines chemotherapy with immunotherapy. If you have one of these cancers and are about to start this treatment, you may be able to join.
This study collects blood, urine, and tissue samples from people with lung, esophageal, or other chest cancers to look at cell changes. It does not test a new treatment—instead, it aims to better understand these cancers through research.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
Hear when a new Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.